1-27355710-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_004672.5(MAP3K6):c.3747C>T(p.Leu1249Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00364 in 1,612,758 control chromosomes in the GnomAD database, including 120 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.018 ( 65 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 55 hom. )
Consequence
MAP3K6
NM_004672.5 synonymous
NM_004672.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.446
Genes affected
MAP3K6 (HGNC:6858): (mitogen-activated protein kinase kinase kinase 6) This gene encodes a serine/threonine protein kinase that forms a component of protein kinase-mediated signal transduction cascades. The encoded kinase participates in the regulation of vascular endothelial growth factor (VEGF) expression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 1-27355710-G-A is Benign according to our data. Variant chr1-27355710-G-A is described in ClinVar as [Benign]. Clinvar id is 782369.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.446 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0552 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K6 | NM_004672.5 | c.3747C>T | p.Leu1249Leu | synonymous_variant | 28/29 | ENST00000357582.3 | NP_004663.3 | |
MAP3K6 | NM_001297609.2 | c.3723C>T | p.Leu1241Leu | synonymous_variant | 27/28 | NP_001284538.1 | ||
MAP3K6 | XM_047433689.1 | c.3654C>T | p.Leu1218Leu | synonymous_variant | 29/30 | XP_047289645.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K6 | ENST00000357582.3 | c.3747C>T | p.Leu1249Leu | synonymous_variant | 28/29 | 1 | NM_004672.5 | ENSP00000350195.2 |
Frequencies
GnomAD3 genomes AF: 0.0175 AC: 2643AN: 151092Hom.: 65 Cov.: 32
GnomAD3 genomes
AF:
AC:
2643
AN:
151092
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00523 AC: 1316AN: 251442Hom.: 26 AF XY: 0.00394 AC XY: 536AN XY: 135902
GnomAD3 exomes
AF:
AC:
1316
AN:
251442
Hom.:
AF XY:
AC XY:
536
AN XY:
135902
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00220 AC: 3216AN: 1461550Hom.: 55 Cov.: 32 AF XY: 0.00198 AC XY: 1441AN XY: 727090
GnomAD4 exome
AF:
AC:
3216
AN:
1461550
Hom.:
Cov.:
32
AF XY:
AC XY:
1441
AN XY:
727090
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0175 AC: 2648AN: 151208Hom.: 65 Cov.: 32 AF XY: 0.0174 AC XY: 1288AN XY: 73882
GnomAD4 genome
AF:
AC:
2648
AN:
151208
Hom.:
Cov.:
32
AF XY:
AC XY:
1288
AN XY:
73882
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
18
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
MAP3K6-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at